Soleno Therapeutics (SLNO) had the highest return last year by a mid-cap US stock, returning 1,825.8%.
Soleno Therapeutics (SLNO) had the highest return last year by a mid-cap US stock, returning 1,825.8%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.